Immunotherapy: A new paradigm for androgen-refractory prostate cancer

被引：0
|
作者：
Loughlin, Kevin R. [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2008年 / 26卷 / 06期
关键词：
D O I：
10.1016/j.urolonc.2008.08.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：575 / 575
页数：1
相关论文
共 50 条
  • [21] Role of Octreoscan in advanced androgen deprivation refractory prostate cancer
    De Vincentis, G.
    Remediani, S.
    Calabrese, P.
    Calandri, E.
    Criscuoli, B.
    Gurciullo, I.
    Liberatore, M.
    Massa, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S130 - S130
  • [22] AP-1 as a mediator of androgen refractory prostate cancer
    Krishna, NS
    Edwards, J
    Underwood, MA
    Grigor, KM
    Bartlett, JMS
    BRITISH JOURNAL OF CANCER, 2002, 86 : S92 - S92
  • [23] Is there a role for androgen ablative therapy for hormone refractory prostate cancer?
    Pinthus, JH
    Kaufman-Francis, K
    Eshhar, Z
    Ramon, J
    JOURNAL OF UROLOGY, 2004, 171 (04): : 158 - 158
  • [24] Drastic Synergy of Lovastatin and Antrodia camphorata Extract Combination against PC3 Androgen-Refractory Prostate Cancer Cells, Accompanied by AXL and Stemness Molecules Inhibition
    Yao, Chih-Jung
    Chang, Chia-Lun
    Hu, Ming-Hung
    Liao, Chien-Huang
    Lai, Gi-Ming
    Chiou, Tzeon-Jye
    Ho, Hsien-Ling
    Kuo, Hui-Ching
    Yang, Ya-Yu
    Whang-Peng, Jacqueline
    Chuang, Shuang-En
    NUTRIENTS, 2023, 15 (21)
  • [25] Androgens Suppress EZH2 Expression Via Retinoblastoma (RB) and p130-Dependent Pathways: A Potential Mechanism of Androgen-Refractory Progression of Prostate Cancer
    Bohrer, Laura R.
    Chen, Shuai
    Hallstrom, Timothy C.
    Huang, Haojie
    ENDOCRINOLOGY, 2010, 151 (11) : 5136 - 5145
  • [26] Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy
    Volovat, Simona Ruxandra
    Scripcariu, Dragos Viorel
    Vasilache, Ingrid Andrada
    Stolniceanu, Cati Raluca
    Volovat, Constantin
    Augustin, Iolanda Georgiana
    Volovat, Cristian Constantin
    Ostafe, Madalina-Raluca
    Andreea-Voichita, Slevoaca-Grigore
    Bejusca-Vieriu, Toni
    Lungulescu, Cristian Virgil
    Sur, Daniel
    Bobac, Diana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [27] Immunotherapy in head and neck cancer: a new paradigm
    Reverdy, Thibaut
    Karabakakian, Andy
    Gau, Max
    Fayette, Jerome
    ANTI-CANCER DRUGS, 2018, 29 (05) : 385 - 386
  • [28] Immunotherapy: a new treatment paradigm in bladder cancer
    Davarpanah, Nicole N.
    Yuno, Akira
    Trepel, Jane B.
    Apolo, Andrea B.
    CURRENT OPINION IN ONCOLOGY, 2017, 29 (03) : 184 - 195
  • [29] A NEW TARGET FOR IMMUNOTHERAPY OF PROSTATE CANCER
    Minev, Boris R.
    Guo, Fang
    Gueorguieva, Ivelina
    Ryu, Sang
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3565 - 3566
  • [30] The new aspects of immunotherapy in prostate cancer
    Mostafa Ghanei
    Majid Shohrati
    Amin Saburi
    Cancer Immunology, Immunotherapy, 2012, 61 : 2375 - 2376
12345